Home
About
Aims & Scope
Journal Policies
Publishing Policies & Ethics
Editorial Board
Editorial Consultants
For Our Reviewers
Our Publisher
International Dermoscopy Society
Indexing & Archiving
Issues
Current
Past Issues
For Authors
Submit a Manuscript
Author Guidelines
Article Processing Charge (APC)
Repository Policy
Submission Forms
Frequently Asked Questions
en
Register
Login
Home
About
Aims & Scope
Journal Policies
Publishing Policies & Ethics
Editorial Board
Editorial Consultants
For Our Reviewers
Our Publisher
International Dermoscopy Society
Indexing & Archiving
Issues
Current
Past Issues
For Authors
Submit a Manuscript
Author Guidelines
Article Processing Charge (APC)
Repository Policy
Submission Forms
Frequently Asked Questions
Language
en
Search
Register
Login
Predictors of Early Response and Relapse in Chronic Spontaneous Urticaria Treated with Omalizumab: The Role of Age, Sex, Disease Duration, and UAS7
Make a Submission
Make a Submission
2024 Journal Impact Factor
2.3
2024 Scopus CiteScore
DPC is proudly supported by
information links
For Readers
For Authors
For Librarians